| Product Code: ETC11589103 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Chimeric Antigen Receptor T-cell Therapy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Chimeric Antigen Receptor T-cell Therapy Market - Industry Life Cycle |
3.4 Israel Chimeric Antigen Receptor T-cell Therapy Market - Porter's Five Forces |
3.5 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Chimeric Antigen Receptor T-cell Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of cancer in Israel |
4.2.2 Increasing investments in research and development of CAR-T cell therapies |
4.2.3 Rising demand for personalized and targeted cancer treatments |
4.3 Market Restraints |
4.3.1 High costs associated with CAR-T cell therapies |
4.3.2 Limited awareness and adoption among healthcare providers and patients |
4.3.3 Stringent regulatory requirements for approval and commercialization |
5 Israel Chimeric Antigen Receptor T-cell Therapy Market Trends |
6 Israel Chimeric Antigen Receptor T-cell Therapy Market, By Types |
6.1 Israel Chimeric Antigen Receptor T-cell Therapy Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CAR T-cell Therapy Products, 2021 - 2031F |
6.1.4 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CAR T-cell Therapy Platforms, 2021 - 2031F |
6.1.5 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CAR T-cell Therapy Services, 2021 - 2031F |
6.1.6 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CAR T-cell Therapy Clinical Trials, 2021 - 2031F |
6.2 Israel Chimeric Antigen Receptor T-cell Therapy Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Gene Editing Technology, 2021 - 2031F |
6.2.3 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By CRISPR Gene Editing, 2021 - 2031F |
6.2.4 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Cytokine Release Syndrome, 2021 - 2031F |
6.2.5 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By T-cell Engineering, 2021 - 2031F |
6.3 Israel Chimeric Antigen Receptor T-cell Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.3.3 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Healthcare Providers, 2021 - 2031F |
6.3.4 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Biopharmaceutical Companies, 2021 - 2031F |
6.3.5 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.4 Israel Chimeric Antigen Receptor T-cell Therapy Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Immunotherapy for Cancer Treatment, 2021 - 2031F |
6.4.3 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Personalized Cancer Treatment, 2021 - 2031F |
6.4.4 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Development of Targeted Cancer Therapies, 2021 - 2031F |
6.4.5 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenues & Volume, By Evaluation of Efficacy in Clinical Trials, 2021 - 2031F |
7 Israel Chimeric Antigen Receptor T-cell Therapy Market Import-Export Trade Statistics |
7.1 Israel Chimeric Antigen Receptor T-cell Therapy Market Export to Major Countries |
7.2 Israel Chimeric Antigen Receptor T-cell Therapy Market Imports from Major Countries |
8 Israel Chimeric Antigen Receptor T-cell Therapy Market Key Performance Indicators |
8.1 Patient response rates to CAR-T cell therapy |
8.2 Number of clinical trials and research studies conducted in Israel |
8.3 Rate of reimbursement by health insurance providers for CAR-T cell therapies |
9 Israel Chimeric Antigen Receptor T-cell Therapy Market - Opportunity Assessment |
9.1 Israel Chimeric Antigen Receptor T-cell Therapy Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Chimeric Antigen Receptor T-cell Therapy Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 Israel Chimeric Antigen Receptor T-cell Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Chimeric Antigen Receptor T-cell Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Chimeric Antigen Receptor T-cell Therapy Market - Competitive Landscape |
10.1 Israel Chimeric Antigen Receptor T-cell Therapy Market Revenue Share, By Companies, 2024 |
10.2 Israel Chimeric Antigen Receptor T-cell Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here